Early screening and proactive care are the future of medicine.

NaNose is revolutionizing disease detection and management with its cutting-edge breathomics technology.

Uniquely designed for primary care settings, it leverages nanotechnology and AI to create breath "fingerprints" from volatile biomarkers, avoiding burdensome molecule concentration analysis.

NaNose’s advanced sensor technology digitizes breath samples, capturing biomarker compositions with high accuracy.

This innovative method enables non-invasive, real-time, and cost-effective diagnostics without needing calibration, capital equipment, or professional operators.

Looking to the future, NaNose enhances clinical decision-making, moves care to lower-cost settings, and improves lives across populations.